2018
DOI: 10.1016/j.micromeso.2018.02.008
|View full text |Cite
|
Sign up to set email alerts
|

A systematic investigation of the bio-toxicity of core-shell magnetic mesoporous silica microspheres using zebrafish model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
8
1
1

Relationship

4
6

Authors

Journals

citations
Cited by 29 publications
(9 citation statements)
references
References 40 publications
0
8
0
1
Order By: Relevance
“…[161][162][163][164][165] Core-shell nanocomposites with mesoporous silica have attracted growing interest in recent years. 166 Combining them with a magnetic core leads to benefits including magnetic cores to control these carriers and mesoporous silica to build such efficient vehicles. Using mesoporous silica-based carriers is one of the exciting concepts, where specific materials are designed to be attached on the surface of the mesoporous silica to seal the entrances to the pores to assure minimum leakage of the therapeutic agents.…”
Section: Mnps@mesoporous Silica Core-shell Drug Carriersmentioning
confidence: 99%
“…[161][162][163][164][165] Core-shell nanocomposites with mesoporous silica have attracted growing interest in recent years. 166 Combining them with a magnetic core leads to benefits including magnetic cores to control these carriers and mesoporous silica to build such efficient vehicles. Using mesoporous silica-based carriers is one of the exciting concepts, where specific materials are designed to be attached on the surface of the mesoporous silica to seal the entrances to the pores to assure minimum leakage of the therapeutic agents.…”
Section: Mnps@mesoporous Silica Core-shell Drug Carriersmentioning
confidence: 99%
“…This effect, although with little relevance in MRI and magnetic guidance, needs to be accounted for if Magnetothermal-chemotherapy (MTCT) is intended [ 55 ]. Despite the improved in vivo stability provided by the silica coating of IOMSNs, this outer shell must also be chemically modified to avoid the interaction with adhesive proteins of the immune system [ 56 ]. This could be achieved by any of the conventional coating procedures known for silica: polyethyleneglycol, [ 40 , 57 ] small targeting elements, functional polymers, zwitterions, small-interfering RNAs (siRNAs), deposition and coating with membranes, although none of these materials have yet reached clinical studies, as far as we know ( Figure 2 ).…”
Section: Inorganic-mesoporous Silica Nanocomposites With Magnetic mentioning
confidence: 99%
“…Testing teratogenicity of clinical drugs involves exposing zebrafish embryos to desired concentrations. Due to small size of the embryos, multiple well plates can be used making it possible to test a high number of animals simultaneously [ 12 , 13 , 33 ]. Drug exposure usually begins around 5-hpf, corresponding to late blastula/early gastrula stages and ends at 96-hpf, where most organs are fully developed [ 34 ].…”
Section: Cardiotoxicity Evaluation In Zebrafishmentioning
confidence: 99%